Nothing Special   »   [go: up one dir, main page]

WO2024191972A3 - Anti-lipocalin-2 antibodies and uses thereof - Google Patents

Anti-lipocalin-2 antibodies and uses thereof Download PDF

Info

Publication number
WO2024191972A3
WO2024191972A3 PCT/US2024/019489 US2024019489W WO2024191972A3 WO 2024191972 A3 WO2024191972 A3 WO 2024191972A3 US 2024019489 W US2024019489 W US 2024019489W WO 2024191972 A3 WO2024191972 A3 WO 2024191972A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibodies
antigen
binding fragments
lipocalin
lcn2
Prior art date
Application number
PCT/US2024/019489
Other languages
French (fr)
Other versions
WO2024191972A2 (en
Inventor
John Kilian
Akiko Koide
Shohei Koide
Jozef Piotr BOSSOWSKI
Thales PAPAGIANNAKOPOLOUS
Original Assignee
New York University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University filed Critical New York University
Publication of WO2024191972A2 publication Critical patent/WO2024191972A2/en
Publication of WO2024191972A3 publication Critical patent/WO2024191972A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

This application relates to antibodies or antigen-binding fragments thereof that bind to Lipocalin-2(LCN2) protein, antibody -drug conjugates comprising such antibodies or antigen-binding fragments, as well as polynucleotides and vectors that encode for such antibodies or antigen-binding fragments. This application further relates to methods of producing the antibodies or antigen-binding fragments and using the antibodies or antigen-binding fragments for treatment of diseases.
PCT/US2024/019489 2023-03-13 2024-03-12 Anti-lipocalin-2 antibodies and uses thereof WO2024191972A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202363451869P 2023-03-13 2023-03-13
US63/451,869 2023-03-13
US202363537089P 2023-09-07 2023-09-07
US63/537,089 2023-09-07
US202463621821P 2024-01-17 2024-01-17
US63/621,821 2024-01-17

Publications (2)

Publication Number Publication Date
WO2024191972A2 WO2024191972A2 (en) 2024-09-19
WO2024191972A3 true WO2024191972A3 (en) 2024-10-31

Family

ID=92756351

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/019489 WO2024191972A2 (en) 2023-03-13 2024-03-12 Anti-lipocalin-2 antibodies and uses thereof

Country Status (1)

Country Link
WO (1) WO2024191972A2 (en)

Also Published As

Publication number Publication date
WO2024191972A2 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
ZA202004730B (en) Anti-claudin 18.2 antibodies and uses thereof
MX2020009366A (en) Anti-cd73 antibodies and uses thereof.
WO2021227307A8 (en) Anti-cd73 antibody and use thereof
NO954626L (en) Single-chain anti-EGFR Fvs and anti-EGFR antibodies
TW200500377A (en) Method of humanizing immune system molecules
WO2022081718A8 (en) Anti-c-c chemokine receptor 8 (ccr8) antibodies and methods of use thereof
MX2020008736A (en) B7-h4 antibody formulations.
WO2021173896A8 (en) Materials and methods for modulating an immune response
WO2019217145A8 (en) Anti-dll3 antibodies and uses thereof
WO2021090062A8 (en) Anti-mesothelin eribulin antibody-drug conjugates and methods of use
ZA202008095B (en) Humanized antibodies against psma
MX2020009522A (en) Anti-folate receptor 1 antibodies and uses thereof.
WO2022034524A3 (en) Antibodies against ilt2 and use thereof
CR20220505A (en) Anti-phf-tau antibodies and uses thereof
MX2023011339A (en) Anti-tau antibodies and uses thereof.
ZA202110285B (en) Antibodies and methods of use
MX2022013920A (en) Anti-tumor associated antigen antibodies and uses thereof.
MX2023002948A (en) Methods and compositions for modulating beta chain mediated immunity.
WO2021254574A3 (en) Cd38 antibodies for the treatment of human diseases
SG148190A1 (en) Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
MX2022015966A (en) Antibodies and methods for treating claudin-associated diseases.
WO2021067633A3 (en) Kir3dl3 is an inhibitory receptor of the immune system and uses thereof
WO2024191972A3 (en) Anti-lipocalin-2 antibodies and uses thereof
MX2022007513A (en) Bispecific antibodies with alternatively matched interchain cycteines and uses thereof.
WO2023154626A3 (en) Anti-il13ra2 antibodies and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24771571

Country of ref document: EP

Kind code of ref document: A2